An 8-year-old child presents with growth failure, alopecia, joint contractures, generalized lipodystrophy, and a high-pitched voice. Physical exam reveals prominent scalp veins, a small face relative to head size, and skin changes resembling scleroderma. Cardiovascular evaluation reveals increased carotid artery pulse wave velocity, consistent with early atherosclerosis. Genetic testing confirms a de novo LMNA mutation. Which medication is FDA-approved to reduce the risk of mortality in this condition?